Understanding how a protein and cholesterol affect pain relief through opioid receptors
Defining the mechanism of PTCHD1 and membrane cholesterol in the regulation of the mu-opioid receptor
['FUNDING_FELLOWSHIP'] · UNIVERSITY OF FLORIDA · NIH-10996216
This study is looking at how a protein called PTCHD1 and cholesterol in cell membranes affect how well the mu-opioid receptor works, which is important for pain relief, to find better ways to manage pain safely.
Quick facts
| Phase | ['FUNDING_FELLOWSHIP'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF FLORIDA (nih funded) |
| Locations | 1 site (GAINESVILLE, UNITED STATES) |
| Trial ID | NIH-10996216 on ClinicalTrials.gov |
What this research studies
This research investigates the role of a protein called PTCHD1 and the presence of cholesterol in the cell membrane on the function of the mu-opioid receptor, which is crucial for pain relief. By studying how these factors influence the receptor's ability to respond to opioids, the research aims to uncover new mechanisms that could enhance pain management. The approach involves examining cellular responses and the local membrane environment to determine how they affect opioid efficacy and tolerance. This could lead to improved strategies for treating pain without the risks associated with current opioid therapies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from acute pain conditions who may benefit from enhanced analgesic therapies.
Not a fit: Patients who do not experience pain or have chronic pain conditions not related to opioid receptors may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective pain relief treatments with fewer side effects and reduced risk of opioid dependence.
How similar studies have performed: Other research has shown promising results in understanding GPCR regulation, but the specific role of PTCHD1 in opioid receptor function is relatively novel.
Where this research is happening
GAINESVILLE, UNITED STATES
- UNIVERSITY OF FLORIDA — GAINESVILLE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: LANKFORD, COLTEN KEITH — UNIVERSITY OF FLORIDA
- Study coordinator: LANKFORD, COLTEN KEITH
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.